Evidence of Interleukin-2-Receptor-Antibody Induction in Low-Risk Living Donor Kidney Transplantation: A Single-Center Pilot Study.

Bernd Martin Jänigen, Susanne Gehrmann,Torben Glatz, Max Seidl,Oliver Thomusch,Eric Peter Prager, Stefan Zschiedrich,Stefan Fichtner-Feigl,Przemyslaw Pisarski,Johanna Schneider

Transplantation Proceedings（2020）

引用 1|浏览5

暂无评分

摘要

•Induction therapy in low-risk kidney recipients.•Interleukin-2-receptor antibody in renal transplantation.•Immunosuppression in living donor kidney transplantation.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要